US Patent Issued to NOBELPHARMA, YUTOKU PHARMACEUTICAL INDUSTRIES on Oct. 27 for "Scopolamine compositions and transdermal patches made therefrom" (Japanese Inventors)

Posted On: 2026-10-27

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,403, issued on Oct. 27, was assigned to NOBELPHARMA Co. LTD. (Tokyo) and YUTOKU PHARMACEUTICAL INDUSTRIES Co. LTD. (Kashima, Japan). "Scopo... Read More

US Patent Issued to NEURODAWN PHARMACEUTICAL on Oct. 27 for "Use of a class of 1,4-dihydro-naphthyridine derivatives in treatment of tumors" (Chinese Inventors)

Posted On: 2026-10-27

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,404, issued on Oct. 27, was assigned to NEURODAWN PHARMACEUTICAL Co. LTD. (Nanjing, China). "Use of a class of 1,4-dihydro-naphthyridine de... Read More

US Patent Issued to PHARMA MAR on Oct. 27 for "Combination of lurbinectedin and immune checkpoint inhibitors" (French Inventors)

Posted On: 2026-10-27

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,405, issued on Oct. 27, was assigned to PHARMA MAR S.A. (Madrid). "Combination of lurbinectedin and immune checkpoint inhibitors" was inven... Read More

US Patent Issued to Dong-A St on Oct. 27 for "Pharmaceutical composition for prevention or treatment of nonalcoholic steatohepatitis" (South Korean Inventors)

Posted On: 2026-10-27

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,406, issued on Oct. 27, was assigned to Dong-A St Co. Ltd. (South Korea). "Pharmaceutical composition for prevention or treatment of nonalc... Read More

US Patent Issued to Emory University, Clemson University Research Foundation on Oct. 27 for "Methods of managing cocaine or other drug addictions" (Georgia, South Carolina Inventors)

Posted On: 2026-10-27

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,407, issued on Oct. 27, was assigned to Emory University (Atlanta) and Clemson University Research Foundation (Clemson, S.C.). "Methods of ... Read More

US Patent Issued to Bengt Fagrell on Oct. 27 for "Anti-ischemic compositions" (Swedish, American Inventors)

Posted On: 2026-10-27

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,408, issued on Oct. 27, was assigned to Bengt Fagrell (Taby, Sweden). "Anti-ischemic compositions" was invented by Bengt Fagrell (Taby, Swe... Read More

US Patent Issued to Blueprint Medicines on Oct. 27 for "Treatment of eosinophilic disorders with avapritinib" (Massachusetts Inventor)

Posted On: 2026-10-27

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,409, issued on Oct. 27, was assigned to Blueprint Medicines Corp. (Cambridge, Mass.). "Treatment of eosinophilic disorders with avapritinib... Read More

US Patent Issued to NATCO PHARMA on Oct. 27 for "EGFR inhibitor for the treatment of head and neck cancer" (Indian Inventors)

Posted On: 2026-10-27

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,410, issued on Oct. 27, was assigned to NATCO PHARMA Ltd. (Hyderabad, India). "EGFR inhibitor for the treatment of head and neck cancer" wa... Read More

US Patent Issued to Biossil, Board of Regents of the University of Texas System on Oct. 27 for "Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent" (Missouri, Texas, Iowa Inventors)

Posted On: 2026-10-27

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,411, issued on Oct. 27, was assigned to Biossil Inc. (Toronto) and Board of Regents of the University of Texas System (Austin, Texas). "Com... Read More

US Patent Issued to Immedica Pharma US on Oct. 27 for "Ganaxolone for use in treatment of super refractory status epilepticus" (Pennsylvania Inventors)

Posted On: 2026-10-27

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,412, issued on Oct. 27, was assigned to Immedica Pharma US Inc. (Radnor, Pa.). "Ganaxolone for use in treatment of super refractory status ... Read More

Exclusive

Category

Source

Publication

Byline

Location

US Patent Issued to NOBELPHARMA, YUTOKU PHARMACEUTICAL INDUSTRIES on Oct. 27 for "Scopolamine compositions and transdermal patches made therefrom" (Japanese Inventors)

US Patent Issued to NEURODAWN PHARMACEUTICAL on Oct. 27 for "Use of a class of 1,4-dihydro-naphthyridine derivatives in treatment of tumors" (Chinese Inventors)

US Patent Issued to PHARMA MAR on Oct. 27 for "Combination of lurbinectedin and immune checkpoint inhibitors" (French Inventors)

US Patent Issued to Dong-A St on Oct. 27 for "Pharmaceutical composition for prevention or treatment of nonalcoholic steatohepatitis" (South Korean Inventors)

US Patent Issued to Emory University, Clemson University Research Foundation on Oct. 27 for "Methods of managing cocaine or other drug addictions" (Georgia, South Carolina Inventors)

US Patent Issued to Bengt Fagrell on Oct. 27 for "Anti-ischemic compositions" (Swedish, American Inventors)

US Patent Issued to Blueprint Medicines on Oct. 27 for "Treatment of eosinophilic disorders with avapritinib" (Massachusetts Inventor)

US Patent Issued to NATCO PHARMA on Oct. 27 for "EGFR inhibitor for the treatment of head and neck cancer" (Indian Inventors)

US Patent Issued to Biossil, Board of Regents of the University of Texas System on Oct. 27 for "Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent" (Missouri, Texas, Iowa Inventors)

US Patent Issued to Immedica Pharma US on Oct. 27 for "Ganaxolone for use in treatment of super refractory status epilepticus" (Pennsylvania Inventors)